CHARGED ALPHATMFrontier AI stock research

ALB · NYSE

Albemarle Corporation

Specialty Chemicals · United States

USD 105.451.0% daily changeQuote 2026-10-06 · USD
Market cap (USD)
US$12.44B
Trailing P/E
390.56x
Forward P/E
9.34x
Quarterly revenue growth
31.1%
Trailing net margin
3.8%
Indicated dividend yield
1.6%

Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-11-04 (provider estimate, not issuer-confirmed).

Company background

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Company website

Q2 2026

Go beyond the headline.

Albemarle (ALB): 86% Of The Q2 Beat Was The Lithium Price - Not Operations

Published 2026-08-07

Comparable businesses

ALB peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricALBAlbemarle CorporationSnapshot 2026-10-06Financial period: 2026-06-30SSLSasol LimitedSnapshot 2026-10-06Financial period: 2026-06-30DDDuPont de Nemours, Inc.Snapshot 2026-10-06Financial period: 2026-06-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$12.44BUS$9.02BUS$17.85BUS$13.43Bn=2
Forward P/EProvider forward earnings estimate9.34x5.05x16.58x10.81xn=2
EV / EBITDAEnterprise value / trailing EBITDA10.24x—12.13x—
Revenue growthLatest quarter vs prior-year quarter31.1%17.9%4.0%10.9%n=2
Operating marginLatest reported quarter27.7%23.1%14.2%18.7%n=2
Free cash flow yieldTrailing cash flow / market cap10.7%—10.3%—
Net debt / EBITDANet debt / trailing EBITDA0.25x1.11x0.91x1.01xn=2
Debt / equityTotal debt / positive book equity0.19x0.65x0.23x0.44xn=2
Trailing P/ETrailing twelve-month earnings390.56x12.68x35.52x24.10xn=2
Price / bookPrice / positive book equity per share1.55x0.94x1.30x1.12xn=2
EV / salesEnterprise value / trailing revenue2.57x—2.75x—
Earnings growthLatest quarter vs prior-year quarter—447.5%149.6%298.5%n=2
Gross marginTrailing twelve months24.0%43.8%35.1%39.5%n=2
Net marginTrailing twelve months3.8%4.5%0.8%2.6%n=2
Return on equityProvider trailing return; positive equity only2.6%8.8%1.8%5.3%n=2
Free cash flow marginTrailing free cash flow / revenue22.6%2.1%26.3%14.2%n=2
Dividend yieldIndicated annual dividend / price1.6%—1.8%—
Earnings payoutProvider trailing dividend payout600.0%0.0%81.5%40.7%n=2
Current ratioCurrent assets / current liabilities2.09x1.79x2.43x2.11xn=2
BetaProvider historical market sensitivity1.36-0.261.080.41n=2

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for ALB

All available reporting periods
Q2 20262026-08-07
Q1 20262026-05-07

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.